Pharmacological Interventions

The purpose of this technical report is to provide an analysis of the available information on methyl 2-{[1-(4-fluorobutyl)-1 H-indole-3-carbonyl]amino}-3,3-dimethylbutanoate (commonly known as 4F-MDMB-BICA), a synthetic receptor...

Online regional training for trainers (ToT) on Course 10 “Managing Medication-Assisted Treatment Programs” (30 November – 3 December 2020) of the Advanced Level of the Universal Treatment Curriculum for Substance Use Disorders (UTC training...

Although COVID-19 usually occurs easily and most people recover quickly, coronavirus can cause very serious complications for certain categories of people, including the elderly and people with weakened immune systems or chronic diseases...

A Regional three-day training for trainers (ToT) on Course 9 “Advanced Pharmacology and Substance Use Disorders” of the Advanced Level of the Universal Treatment Curriculum for Substance Use Disorders (UTC training package) was launched via...

A 4 days virtual training on Universal Prevention Curriculum Course 2, “Physiology and Pharmacology for Prevention Specialists” from 02 to 05 November 2020 kicked off today by UNODC to add into pool of national master trainers on substance...

Background In 2019, four Central Asian countries – Kazakhstan, Kyrgyzstan, Tajikistan and Uzbekistan – piloted the implementation of UNODC's quality assurance mechanisms/tools for the treatment of drug use disorders. The event was held...

This international consensus statement can be used by clinicians and patients together in a shared decision-making process to select the best interventions and to reach optimal outcomes in adolescent patients with concurrent ADHD and SUD.